Eli Lilly and Company (NYSE:LLY) saw an upside of 0.35% to $551.95 after adding $1.9 on Tuesday. The 5-day average trading volume is 2,249,672 shares of the company’s common stock. It has gained $553.50 in the past week and touched a new high 2 times within the past 5 days. An average of 3,169,468 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 2,880,117.
LLY’s 1-month performance is 20.17% or $89.21 on its low of $446.56 reached on 07/26/23. The company’s shares have touched a 52-week low of $296.32 and high of $553.50, with the stock’s rally to the 52-week high happening on 08/21/23. YTD, LLY has achieved 50.87% or $185.41 and has reached a new high 31 times. However, the current price is down -0.28% from the 52-week high price.
Insider Transactions
LLY stock investors last saw insider trading activity on Aug 15.LILLY ENDOWMENT INC (10% Owner) most recently sold 50,222 shares at $543.72 per share on Aug 15. This transaction cost the insider $27,306,747. 10% Owner, LILLY ENDOWMENT INC, sold 164,778 shares at a price of $539.08 on Aug 14. Then, on Aug 11, 10% Owner LILLY ENDOWMENT INC sold 83,039 shares at a price of $528.50 per share. This transaction amounted to $43,886,430.
Valuation Metrics
LLY stock has a beta of 0.29. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 17.47 while the price-to-book (PB) in the most recent quarter is 44.86, with the price to cash flow ratio at 160.54.
Eli Lilly and Company’s quick ratio for the period ended June 29 was 0.90, with the current ratio over the same period at 1.10. As well, the company’s long term debt to equity for the quarter ending June 29 was 1.64, while the total debt to equity was 1.70. In terms of profitability, the gross margin trailing 12 months is 77.80%. The trailing 12-month EBITDA margin is 34.35%. The firm’s gross profit as reported stood at $21.91 billion against revenue of $28.54 billion.
Earnings Surprise
For the quarterly period ending June 29 this year, Net income and sales went up compared to those figures reported in the previous quarter. Net income grew 45.98% to $1.76 billion, while revenue of $1.34 billion was 23.72% off the previous quarter. Analysts expected LLY to announce $1.98 per share in earnings in its latest quarter, but it posted $2.11, representing a 6.60% surprise. EBITDA for the quarter stood at more than $2.49 billion. LLY stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 43.66 billion, with total debt at $18.95 billion. Shareholders hold equity totaling $949.29 million.
Let’s look briefly at Eli Lilly and Company (LLY) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 21 August was 80.31% to suggest the stock is trending Overbought, with historical volatility in this time period at 17.59%.
The stock’s 5-day moving average is $546.33, reflecting a +0.85% or $4.63 change from its current price. LLY is currently trading +20.48% above its 20-day SMA, +64.13% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by +23.59% and SMA200 by+55.30%.
Stochastic %K and %D was 96.19% and 93.14% and the average true range (ATR) pointed at 12.38. The RSI (14) points at 77.75%, while the 14-day stochastic is at 97.89% with the period’s ATR at 12.15. The stock’s 9-day MACD Oscillator is pointing at 8.59 and 30.21 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for Eli Lilly and Company (NYSE: LLY), Jefferies upgraded it to a Buy rating. They previously had a Hold rating on the stock.
